ACM
AGN

Alpha Capital Management’s Allergan plc AGN Stock Holding History

Alpha Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-16,894
Closed -$2.99M – 111
2020
Q1 		$2.99M Buy
16,894
+154
+0.9% +$29K 1.32% 16
2019
Q4 		$3.2M Sell
16,740
-250
-1% -$45.1K 1.18% 18
2019
Q3 		$2.86M Sell
16,990
-3,134
-16% -$511K 1.06% 28
2019
Q2 		$3.37M Buy
20,124
+4,346
+28% +$602K 1.27% 15
2019
Q1 		$2.31M Buy
15,778
+1,902
+14% +$276K 0.91% 45
2018
Q4 		$1.85M Buy
+13,876
New +$2.27M 0.87% 45

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Alpha Capital Management's AGN Position: Q2 2020 in Review

Alpha Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 16,894 shares — an estimated $2.99M sold.

Alpha Capital Management first reported a position in AGN in Q4 2018 and held it in 6 quarters. The position peaked at $3.37M in Q2 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Alpha Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Alpha Capital Management sold 16,894 Allergan plc shares in Q2 2020, an estimated $2.99M.
  • Alpha Capital Management first reported a position in Allergan plc in Q4 2018 and held it in 6 quarters.
  • Alpha Capital Management's Allergan plc position peaked at $3.37M in Q2 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Alpha Capital Management's 13F filing for Q2 2020, filed 29 Jul 2020.